PillRx only · Tablet, Film Coated, Extended Release · Oral
Paliperidone
Paliperidone
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 14 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.019
Latest avg · Jul 22, 2026
-20%
Since Dec 17, 2025
4
Active US suppliers
67%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
54K
Rx · 2026 Q1
1.8M
Units dispensed
+50%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES, INC. | unknown | 8 | SUPPLYING |
| NorthStar RxLLC | unknown | 4 | SUPPLYING |
| Archis Pharma LLC | unknown | 3 | SUPPLYING |
| Major Pharmaceuticals | unknown | 3 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 28, 2022RECALLRecall (Class II): PALIPERIDONE EXTENDED-RELEASE TABLETS, 9 mg, 100 Tablets per carton (10 x 10 blister packs), Rx only, Manufactured by: …
Failed Dissolution Specifications — Recalling firm: The Harvard Drug Group — Nationwide within the United States